About Sarasota Clinical Research
Clinical Trials at Sarasota Clinical Research
During the past decade, Sarasota Clinical Research conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 5 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Sarasota Clinical Research" #1 sponsor was "Aimmune Therapeutics, Inc." with 3 trials, followed by "Celldex Therapeutics" with 2 trials
sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "ALK-Abelló A/S" with 1 trials sponsored and "DBV Technologies"
with 1 trials sponsored. Other sponsors include 1 different institutions and
companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Sarasota Clinical Research"
#1 collaborator was "Iqvia Pty Ltd" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Sarasota Clinical Research
According to Clinical.Site data, the most researched conditions in "Sarasota Clinical Research" are
"Asthma" (4 trials), "Peanut Allergy" (4 trials), "Chronic Spontaneous Urticaria" (2 trials), "Allergic Rhinitis Due to Dermatophagoides Farinae" (1 trials) and "Allergic Rhinitis Due to Dermatophagoides Pteronyssinus" (1 trials). Many other conditions were trialed in "Sarasota Clinical Research" in a lesser frequency.
Clinical Trials Intervention Types at Sarasota Clinical Research
Most popular intervention types in "Sarasota Clinical Research" are "Drug" (10 trials), "Biological" (6 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "AR101" (3 trials), "Lebrikizumab" (2 trials), "CDX-0159" (1 trials) and "Ensifentrine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Sarasota Clinical Research
The vast majority of trials in "Sarasota Clinical Research" are
15 trials for "All" genders.
Clinical Trials Status at Sarasota Clinical Research
Currently, there are NaN active trials in "Sarasota Clinical Research".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 10 completed trials in Sarasota Clinical Research,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Sarasota Clinical Research, 1 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".